Frederic Moll Net Worth

The estimated Net Worth of Frederic H Moll is at least $113 Milhão dollars as of 21 February 2024. Mr. Moll owns over 60,000 units of Shockwave Medical stock worth over $96,247,655 and over the last 21 years he sold SWAV stock worth over $16,973,442. In addition, he makes $185,000 as Independent Director at Shockwave Medical.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Moll SWAV stock SEC Form 4 insiders trading

Frederic has made over 18 trades of the Shockwave Medical stock since 2003, according to the Form 4 filled with the SEC. Most recently he sold 60,000 units of SWAV stock worth $15,443,400 on 21 February 2024.

The largest trade he's ever made was buying 333,333 units of Shockwave Medical stock on 9 August 2018 worth over $500,000. On average, Frederic trades about 10,806 units every 134 days since 2003. As of 21 February 2024 he still owns at least 287,521 units of Shockwave Medical stock.

You can see the complete history of Mr. Moll stock trades at the bottom of the page.

Frederic Moll biography

Frederic Moll M.D. serves as Independent Director of the Company. Dr. Moll has been a member and served as Chairman of the board of Restoration Robotics, Inc. since November 2002. Dr. Moll is also a co-founder, and, since September 2012, has been the Chairman and Chief Executive Officer of Auris Health, Inc. Dr. Moll has served in a leadership capacity of Circuit Therapeutics since 2011. From 2002 to 2010, Dr. Moll served as the Chief Executive Officer of Hansen Medical, which he also co-founded. Previously, Dr. Moll co-founded Intuitive Surgical, Inc. and from 1995 to 2002 served as its first Chief Executive Officer. Dr. Moll also co-founded Endo-Therapeutics, Inc. and Origin, which later became an operating company within Guidant Corporation following its acquisition by Eli Lilly & Company. Dr. Moll serves on the boards of directors of IntersectENT, Inc. Dr. Moll received a B.A. in economics from the University of California at Berkeley, an M.S. in management from Stanford University and an M.D. from the University of Washington.

What is the salary of Frederic Moll?

As the Independent Director of Shockwave Medical, the total compensation of Frederic Moll at Shockwave Medical is $185,000. There are 9 executives at Shockwave Medical getting paid more, with Douglas Godshall having the highest compensation of $2,208,320.

How old is Frederic Moll?

Frederic Moll is 68, he's been the Independent Director of Shockwave Medical since 2016. There are 2 older and 13 younger executives at Shockwave Medical. The oldest executive at Shockwave Medical Inc. is John M. Adams, 74, who is the Co-Founder and Technical Advisor.

What's Frederic Moll's mailing address?

Frederic's mailing address filed with the SEC is C/O SHOCKWAVE MEDICAL, INC., 5403 BETSY ROSS DRIVE, SANTA CLARA, CA, 95054.

Insiders trading at Shockwave Medical

Over the last 6 years, insiders at Shockwave Medical have traded over $488,603,927 worth of Shockwave Medical stock and bought 30,000 units worth $510,000 . The most active insiders traders include James E Deerfield Mgmt L.P...., Antoine Papiernik, eCapital Vii Fcpr Sofinnova. On average, Shockwave Medical executives and independent directors trade stock every 8 days with the average trade being worth of $10,693,924. The most recent stock trade was executed by Trinh Phung on 17 May 2024, trading 19,763 units of SWAV stock currently worth $121,740.

What does Shockwave Medical do?

shockwave medical is revolutionizing the interventional treatment of advanced cardiovascular disease by developing technology that targets calcified plaque. inspired by 30-years of safety and efficacy in kidney stone treatment, our lithoplasty® family of catheters delivers localized lithotripsy at the site of cardiovascular calcium that enables gentle balloon dilatation of calcified, stenotic arteries. lithoplasty devices use sonic pressure waves to preferentially impact hard tissue, disrupting calcium, while leaving soft tissue undisturbed. an integrated balloon catheter then dilates the calcified lesion at low-pressure, restoring blood flow. in peripheral vascular clinical study of moderate and severely calcified lesions in 95 patients, lithoplasty technology demonstrated safety and consistent procedure success with low procedural complications. the technology is inherently familiar, easy to use, operates with just the push of a button, and works with existing cardiovascular treatmen

Complete history of Mr. Moll stock trades at Biolase Inc, Intersect ENT Inc, Intuitive Surgical Inc, Shockwave Medical, eVenus Concept

Shockwave Medical executives and stock owners

Shockwave Medical executives and other stock owners filed with the SEC include:

• Douglas Godshall,
  President, Chief Executive Officer, Director
• Daniel Puckett,
  Chief Financial Officer
• Douglas E. Godshall,
  Pres, CEO & Director
• Isaac Zacharias,
  Chief commercial Officer
• Isaac Zacharias,
  Chief Commercial Officer
• Daniel Puckett MBA,
  CFO, Principal Financial Officer & Sec.
• Colin Cahill,
  Independent Director
• F. Thomas Watkins,
  Independent Director
• Antoine Papiernik,
  Independent Director
• Frederic Moll,
  Independent Director
• C. Raymond Larkin,
  Independent Chairman of the board
• Laura Francis,
  Independent Director
• Maria Sainz,
  Director
• Trinh Phung,
  Chief Accounting Officer, Principal Accounting Officer & VP of Fin.
• Robert Fletcher,
  VP of Marketing
• Rob Williamson Jr.,
  VP of Sales
• Hajime Tada J.D.,
  Gen. Counsel & Sec.
• Debbie Kaster,
  Head of Investor Relations
• Mike Maszy,
  VP of Operations
• John M. Adams,
  Co-Founder and Technical Advisor
• Daniel Hawkins,
  Founder and Sr. Advisor
• Sara Toyloy,
  Director
• Capital Vii Fcpr Sofinnova,
  10% owner
• James E Deerfield Mgmt L.P....,
  
• Dan Puckett,
  Chief Financial Officer
• Associates Vii, L.P.Venrock...,
  
• Trinh Phung,
  SVP, Finance
• Kevin J. Ballinger,
  Director
• Renee Gaeta,
  Chief Financial Officer